Flexible Strategies for Centralized Public Procurement

Albano, Gian Luigi; Sparro, Marco

doi:10.5202/rei.v1i2.4

Cited by 21 publications

(22 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Também é considerada uma alavanca para atingir metas políticas mais amplas, como desenvolvimento tecnológico e inovação (ALBANO; SPARRO, 2010). O processo de transferência de tecnologia foi adotado pelo governo como estratégia para catch up tecnológico na área de medicamentos, setor onde a dependência externa do país é grande (GADELHA et al, 2013;SORTE JUNIOR, 2012;TIGRE, 2006).…”

Section: Discussionunclassified

Compras federais de antineoplásicos no Brasil: análise do mesilato de imatinibe, trastuzumabe e L-asparaginase, 2004-2013

Moraes

Osório-de-Castro

Caetano

2016

Physis

View full text Add to dashboard Cite

Observou-se redução nos PMP do imatinibe, mesmo antes da centralização da compra pelo MS. O PMP do transtuzumabe foi reduzido em 57% após a incorporação pela CONITEC e a centralização de compras. As quantidades e preços da L-asparaginase variaram entre os órgãos. Diferentemente dos outros medicamentos, verificou-se significativa elevação de 117% no PMP da L-asparaginase, refletindo o desabastecimento no mercado mundial. Conclusões: A inclusão em Parcerias de Desenvolvimento Produtivo e a centralização das compras pelo MS parecem justificar as reduções de preço do imatinibe e trastuzumabe, reforçando a tese do uso do poder de compra do Estado. Estas reduções podem contribuir na ampliação de seu acesso no SUS. Palavras-chave: assistência farmacêutica; preço de medicamento; antineoplásicos; compras públicas; parcerias público-privadas.

show abstract

Section: Discussionunclassified

Compras federais de antineoplásicos no Brasil: análise do mesilato de imatinibe, trastuzumabe e L-asparaginase, 2004-2013

Moraes

Osório-de-Castro

Caetano

2016

Physis

View full text Add to dashboard Cite

show abstract

“…On the other hand, the literature stresses several disadvantages of having recourse to a central agency: higher coordination, set-up and maintenance costs, the impossibility of satisfying unique requirements, loss of relationships with local suppliers, possible exclusion of small firms, and potential lock-in phenomena (THAI, 2009;TELLA and VIROLAINEN, 2005;ALBANO and SPARRO, 2010).…”

Section: Centralization Versus Decentrali-zation Of Procurementmentioning

confidence: 98%

The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption

Baldi¹,

Vannoni

2015

Regional Studies

View full text Add to dashboard Cite

BALDI S. and VANNONI D. The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption, Regional Studies. This paper deals with the open issue regarding centralized versus decentralized public procurement strategy. Using a unique dataset on tender prices of selected drugs for hospital usage provided by a sample of 52 Italian local health service providers (aziende sanitarie locali -ASLs) between 2009 and 2012, the paper tests which procurement system (centralized, decentralized or hybrid) performs better. Controlling for several covariates, including measures of institutional quality and corruption, it finds that centralized and hybrid procurers pay lower prices than decentralized units. Moreover, the results show that in areas in which institutional quality is lower or corruption is higher, the effect of centralization in terms of negotiating lower prices is much stronger, with savings of up to 60% of the price paid by ASLs that procure independently. Public procurementCentralization Decentralization Pharmaceutical spending BALDI S. and VANNONI D. 集中化对药品採购价格的影响：制度质量与贪腐的角色，区域研究。本文处理有关集中化与去中心化的公共採购策略之开放议题。本文运用五十二个意大利地方健康服务供给者(aziende sanitarie localiASLs)样本所提供的2009年至2012年医院选定用药的投标价格之特殊数据集，测试何种採购系统(集中化、去中心化或混合式)表现较佳。本研究控制包含制度质量与贪腐的测量之若干共变量后，发现较去中心化而言，集中式和混合式的採购每单位支付的价格较低。此外，研究结果显示，在制度质量较低或贪腐较为严重的地区中，集中化在协商较低价格方面的影响更为显着，且最多节省了ASLs各自採购所支付的价格的百分之六十。公共採购集中化去中心化药品花费 BALDI S. et VANNONI D. L'impact de la centralisation sur le prix d'offre des produits pharmaceutiques: le rôle de la qualité institutionnelle et de la corruption, Regional Studies. Ce présent article cherche à aborder la question ouverte de la centralisation contre la décentralisation des commandes publiques. À partir d'un ensemble de données unique sur les prix figurant dans les appels d'offre pour une série de médicaments à l'usage des hôpitaux et provenant d'un échantillon de 52 prestataires de services de santé locaux (aziende sanitarie locali -ASL) entre 2009 et 2012, l'article cherche à tester lequel des systèmes d'approvisionnement (centralisé, décentralisé ou hybride) donne les meilleurs résultats. Tenant compte de plusieurs covariables, y compris des mesures de la qualité institutionnelle et de la corruption, il s'avère que les acheteurs centralisés et hybrides paient des prix inférieurs que ne le paient les unités décentralisées. En outre, les résultats indiquent que dans les zones où la qualité institutionnelle est plus faible ou la corruption est plus forte, l'effet de la centralisation, en termes de la négociation des prix, est beaucoup plus forte, dont les économies se chiffrent à jusqu'à 60% du prix payé par les ASL qui s'approvisionnent indépendamment. Commandes publiques Centralisation Décentralisation Dépenses de produits pharmaceutiques BALDI S. und VANNONI D. Auswirkung von Zentralisierung auf die Preise bei der pharmazeutischen Auftragsvergabe: die Rolle der institutionellen Qualität und Korruption, Regional Studies. In diesem Beitrag wird die offene Frage einer zentralisierten...

show abstract

“…According to Albano and Sparro (2010), the main economic justification for public purchases centralization can be found in the need to reduce the related costs. It is a fact that several countries feature national (i.e.…”

Section: Gpp and "Demand" Centralizationmentioning

confidence: 99%

Is Public Procurement Going Green? Experiences and Open Issues

2011

View full text Add to dashboard Cite

Abstract:Public purchasing authorities are in a leading position for the introduction, promotion and development of green procurement. Indeed, the public sector can influence green procurement both by designing suitable policies and by driving "green" markets through the significant share of public purchases on GDP. The European Commission (EC) has emphasized the importance of cost-efficient GPP and, in compliance with the EU's Integrated Product Policy (IPC), Member States have been encouraged to devise national action plans. As a result, many countries have already adopted steps in the direction of greening public purchases. The aim of our paper is twofold: first, we focus on the state of the art in terms of the EU and Italian Legislation; then, we highlight open questions related to crucial issues in GPP implementation, with a particular attention to the design of green tenders and awarding criteria to account for environmental quality in public purchasing procedures.

show abstract

Flexible Strategies for Centralized Public Procurement

Cited by 21 publications

References 21 publications

Compras federais de antineoplásicos no Brasil: análise do mesilato de imatinibe, trastuzumabe e L-asparaginase, 2004-2013

Compras federais de antineoplásicos no Brasil: análise do mesilato de imatinibe, trastuzumabe e L-asparaginase, 2004-2013

The impact of centralization on pharmaceutical procurement prices: the role of institutional quality and corruption

Is Public Procurement Going Green? Experiences and Open Issues

Contact Info

Product

Resources

About